Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy
Ribonucleotide reductase (RR) is a crucial enzyme in de novo DNA synthesis, where it catalyses the rate determining step of dNTP synthesis. RRs consist of a large subunit called RR1 (α), that contains two allosteric sites and one catalytic site, and a small subunit called RR2 (β), which houses a tyr...
Saved in:
Main Authors: | Prem Singh Kaushal (Author), Qun Wan (Author), Chris G. Dealwis (Author), Jianying Kiser (Author), Hai Xu (Author), James W. Fairman (Author), Andrew Zhang (Author), Sanath R. Wijerathna (Author), Md. Faiz Ahmad (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2011-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure-guided design of anti-cancer ribonucleotide reductase inhibitors
by: Tessianna A. Misko, et al.
Published: (2019) -
Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox
by: Inayat Mohammed S, et al.
Published: (2010) -
Ribonucleotide reductase small subunit M2 promotes the proliferation of esophageal squamous cell carcinoma cells via HuR-mediated mRNA stabilization
by: Jing Zhang, et al.
Published: (2024) -
Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
by: Kentaro Minami, et al.
Published: (2015) -
Design and synthesis of potential ribonucleotide reductase enzyme (RNR) inhibitors as antileukemic and/or antiviral 2'-deoxymethylene nucleosides
by: Khairia M. Youssef, et al.
Published: (2015)